Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
26.08
-1.54 (-5.58%)
At close: Mar 10, 2026, 4:00 PM EDT
26.47
+0.39 (1.50%)
After-hours: Mar 10, 2026, 4:51 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.59 billion as of March 10, 2026. Its market cap has increased by 6.98% in one year.
Market Cap
2.59B
Enterprise Value
1.50B
1-Year Change
6.98%
Ranking
Category
Stock Price
$26.08
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.59B, an increase of 690.02%. That is a compound annual growth rate of 40.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.74B | 0.26% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 3.08B |
| Edgewise Therapeutics | 3.07B |
| Viridian Therapeutics | 3.03B |
| Catalyst Pharmaceuticals | 3.03B |
| Arcus Biosciences | 2.94B |
| Dyne Therapeutics | 2.92B |
| Vera Therapeutics | 2.78B |
| Travere Therapeutics | 2.67B |